Emergent BioSolutions Cash and Cash Equivalents 2011-2026 | EBS

Annual Cash and Cash Equivalents Emergent BioSolutions

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
112 M	643 M	576 M	621 M	168 M	112 M	178 M	272 M	313 M	280 M	179 M	142 M	144 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
643 M	112 M	288 M

Quarterly Cash and Cash Equivalents Emergent BioSolutions

2023-Q3	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
87.8 M	643 M	241 M	-	436 M	576 M	404 M	448 M	548 M	621 M	621 M	621 M	621 M	168 M	168 M	168 M	168 M	112 M	112 M	112 M	112 M	178 M	178 M	178 M	178 M	272 M	272 M	272 M	272 M	313 M	313 M	313 M	313 M	280 M	280 M	280 M	280 M	179 M	179 M	179 M	179 M	142 M	142 M	142 M	142 M	144 M	144 M	144 M	144 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
643 M	87.8 M	271 M

Cash and Cash Equivalents of other stocks in the Drug manufacturers industry

Issuer	Cash and Cash Equivalents	Price	% 24h	Market Cap	Country
Zynerba Pharmaceuticals ZYNE	50.6 M	-	-	$ 55.5 M	USA
Alimera Sciences ALIM	12.1 M	-	-	$ 142 M	USA
Adamis Pharmaceuticals Corporation ADMP	1.08 M	-	0.86 %	$ 117 M	USA
Aerie Pharmaceuticals AERI	37.2 M	-	-	$ 754 M	USA
Canopy Growth Corporation CGC	114 M	$ 1.2	1.27 %	$ 129 M	Canada
AcelRx Pharmaceuticals ACRX	8.86 M	-	7.5 %	$ 6.35 M	USA
Agile Therapeutics AGRX	2.56 M	-	10.11 %	$ 58.2 M	USA
Catalent CTLT	289 M	-	-	$ 11.5 B	USA
DURECT Corporation DRRX	28.4 M	-	-	$ 50.1 M	USA
Eagle Pharmaceuticals EGRX	55.3 M	-	-39.89 %	$ 27.7 M	USA
Endo International plc ENDP	778 M	-	-	$ 28.9 M	Irlanda
Calliditas Therapeutics AB (publ) CALT	956 M	-	-0.1 %	$ 2.03 B	Schweden
Evoke Pharma EVOK	4.74 M	-	-	$ 36.6 M	USA
HEXO Corp. HEXO	83.2 M	-	2.45 %	$ 38.1 M	Canada
OrganiGram Holdings OGI	24.6 M	$ 1.69	0.9 %	$ 402 M	Canada
Athenex ATNX	30.4 M	-	-23.39 %	$ 1.76 M	USA
Avadel Pharmaceuticals plc AVDL	51.4 M	$ 21.48	-0.12 %	$ 2.04 B	France
Evolus EOLS	87 M	$ 5.72	-3.3 %	$ 355 M	USA
Harrow Health HROW	74.1 M	$ 50.79	-5.07 %	$ 1.66 B	USA
Jupiter Wellness JUPW	349 K	-	-	$ 33.6 M	USA
China Pharma Holdings CPHI	600 K	$ 1.38	9.13 %	$ 24.1 M	China
Sundial Growers SNDL	218 M	$ 1.66	-1.19 %	$ 3.37 M	Canada
Sonoma Pharmaceuticals SNOA	5.37 M	$ 3.8	-	$ 4.72 M	USA
Bausch Health Companies BHC	947 M	$ 7.9	3.41 %	$ 2.88 B	Canada
Lannett Company LCI	87.9 M	-	1.15 %	$ 7.11 M	USA
Neoleukin Therapeutics NLTX	148 M	-	-	$ 193 M	Canada
Cumberland Pharmaceuticals CPIX	18 M	$ 5.14	8.9 %	$ 72.3 M	USA
Organogenesis Holdings ORGO	136 M	$ 4.32	-0.92 %	$ 569 M	USA
Pacira BioSciences PCRX	277 M	$ 26.13	3.24 %	$ 1.21 B	USA
Aurora Cannabis ACB	138 M	$ 4.23	-0.25 %	$ 86.3 M	Canada
Rockwell Medical RMTI	8.98 M	$ 0.95	2.85 %	$ 22.2 M	USA
PetIQ PETQ	116 M	-	1.64 %	$ 400 M	USA
Perrigo Company plc PRGO	559 M	$ 14.7	-0.47 %	$ 2.02 B	USA
ProPhase Labs PRPH	9.11 M	-	-	$ 5.07 M	USA
Veru VERU	24.9 M	$ 2.34	0.43 %	$ 316 M	USA
Radius Health RDUS	112 M	-	-	$ 1.42 B	USA
Recro Pharma REPH	8.1 M	-	-4.76 %	$ 65.3 M	USA
cbdMD YCBD	2.45 M	$ 1.11	-3.91 %	$ 4.79 M	USA
Relmada Therapeutics RLMD	4.09 M	$ 4.3	5.39 %	$ 129 M	USA
OptiNose OPTN	73.7 M	-	-	$ 1.08 B	USA
Assertio Holdings ASRT	73.4 M	$ 9.35	-1.86 %	$ 664 M	USA
PLx Pharma PLXP	69.4 M	-	-27.8 %	$ 2.56 M	USA
Solid Biosciences SLDB	80.2 M	$ 5.58	1.64 %	$ 228 M	USA
SCYNEXIS SCYX	34 M	$ 0.64	-0.12 %	$ 30.6 M	USA
Tricida TCDA	21.1 M	-	-	$ 3.25 M	USA
Tilray TLRY	207 M	$ 8.95	-3.35 %	$ 5.53 B	Canada
TherapeuticsMD TXMD	4.33 M	$ 2.0	-2.0 %	$ 20.9 M	USA
Zomedica Corp. ZOM	13 M	-	-0.21 %	$ 98 M	USA